We have located links that may give you full text access.
Hand-assisted laparoscopic aortobifemoral bypass for occlusive disease. Early and mid-term results.
European Journal of Vascular and Endovascular Surgery 2005 November
OBJECTIVES: To evaluate the early and mid-term results of hand-assisted laparoscopic surgery (HALS) for aorto-iliac reconstruction.
DESIGN: Prospective survey.
MATERIALS AND METHODS: Between February 2002 and January 2004, 46 patients received an aortobifemoral bypass for advanced occlusive disease by HALS.
RESULT: There was one conversion to open surgery. Mortality was 4.5%. The median return to solid oral diet took 36 h (24-182), the median hospital stay was 5 days (3-26). Primary patency rate at 1 year was 97.5%. The incidence of incisional hernia was 19.5%.
CONCLUSIONS: HALS aorto-iliac reconstruction should be considered as a minimal invasive technique with good early and mid-term results.
DESIGN: Prospective survey.
MATERIALS AND METHODS: Between February 2002 and January 2004, 46 patients received an aortobifemoral bypass for advanced occlusive disease by HALS.
RESULT: There was one conversion to open surgery. Mortality was 4.5%. The median return to solid oral diet took 36 h (24-182), the median hospital stay was 5 days (3-26). Primary patency rate at 1 year was 97.5%. The incidence of incisional hernia was 19.5%.
CONCLUSIONS: HALS aorto-iliac reconstruction should be considered as a minimal invasive technique with good early and mid-term results.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app